Is antiplatelet therapy safe after intracerebral hemorrhage? Commentary

Nature Clinical Practice Cardiovascular Medicine

Volumn 3, Issue 6, 2006, Pages 298-299

  Hill, Michael D ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Antiplatelet therapy; Intracerebral hemorrhage

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL;

ANTICOAGULANT THERAPY; BRAIN HEMORRHAGE; CLINICAL TRIAL; COHORT ANALYSIS; DRUG SAFETY; DRUG USE; HUMAN; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK ASSESSMENT; SHORT SURVEY; SURVIVAL; THROMBOSIS;

EID: 33744519126     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio0579     Document Type: Short Survey

References (2)

1. Diener HC et al. (2004) Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind, placebo-controlled trial. Lancet 364: 331-337
2. Hill MD et al. (2000) Rate of stroke recurrence in patients with primary intracerebral hemorrhage. Stroke 31: 123-127